Free Newsletter
SPOTLIGHT: Merck profits jump by 62 percent
Free newsletter via e-mail
Tools
Merck & Co. saw its profits soar by 62 percent to $1.53 billion, on a 12 percent jump in revenue and lower admin and overhead costs; Singulair was the big seller for the quarter at $1 billion. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: